Tapewire

Nasdaq · USD

CELC

Celcuity Inc.

Export transactions ↓
Tapewire entity
3991
SEC CIK
0001603454
Parsed reports
187

Last 12 months

Inside the activity.

0 purchase rows · 17 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202503
Jan 202601
Feb 202600
Mar 202602
Apr 202600
May 202607
Jun 202600
Jul 202602
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 07, 2026 Filed Oct 9, 2026 20:13 UTC
Furcht LeoDirector
Exercise / conversionStock Option (right to buy) · Derivative 250 $0.00 Strike: $7.60 $0.00
Disclosure

SEC source: 0001775749-26-000004 · form4-10092026_081009.xml · derivative · entry 2

Furcht Leo · CIK 0001775749 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 250 shares

Expires 2026-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
October 07, 2026 Filed Oct 9, 2026 20:13 UTC
Furcht LeoDirector
Exercise / conversionCommon Stock 250 $7.60 $1,900.00
Disclosure

SEC source: 0001775749-26-000004 · form4-10092026_081009.xml · nonDerivative · entry 1

Furcht Leo · CIK 0001775749 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,780

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 21:08 UTC GrantCommon Stock 893 $0.00 $0.00
Disclosure

SEC source: 0001202335-26-000007 · form4-10052026_091004.xml · nonDerivative · entry 1

GRYSKA DAVID W · CIK 0001202335 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 893

F1 · shares: Represents restricted stock units that will vest upon the earlier of (i) the 2027 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2027.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 20:18 UTC
Sullivan Brian F.Director · Chief Executive Officer
GrantPerformance Stock Units · Derivative 120,000 $0.00 $0.00
Disclosure

SEC source: 0000940454-26-000002 · form4-08182026_080827.xml · derivative · entry 4

Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Celcuity Inc. (the "Company") common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds.

F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of Celcuity Inc. (the "Company") common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds.

F3 · derivative.expiration_date: Each performance stock unit represents a contingent right to receive one share of Celcuity Inc. (the "Company") common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 20:18 UTC
Sullivan Brian F.Director · Chief Executive Officer
GrantCommon Stock 80,000 $0.00 $0.00
Disclosure

SEC source: 0000940454-26-000002 · form4-08182026_080827.xml · nonDerivative · entry 1

Sullivan Brian F. · CIK 0000940454 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,450,199

F1 · shares: 25% of the total number of restricted stock units vests on the first day of the month following each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 20:19 UTC
Laing Lance G.Director · Chief Science Officer
GrantPerformance Stock Units · Derivative 10,000 $0.00 $0.00
Disclosure

SEC source: 0001716041-26-000004 · form4-08182026_080858.xml · derivative · entry 2

Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Celcuity Inc. (the "Company") common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds.

F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of Celcuity Inc. (the "Company") common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds.

F2 · derivative.expiration_date: Each performance stock unit represents a contingent right to receive one share of Celcuity Inc. (the "Company") common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 20:19 UTC
Laing Lance G.Director · Chief Science Officer
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001716041-26-000004 · form4-08182026_080858.xml · nonDerivative · entry 1

Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,271,000

F1 · shares: 25% of the total number of restricted stock units vests on the first day of the month following each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 20:17 UTC
Hahne VickyChief Financial Officer
GrantPerformance Stock Units · Derivative 10,000 $0.00 $0.00
Disclosure

SEC source: 0001716043-26-000002 · form4-08182026_080833.xml · derivative · entry 2

Hahne Vicky · CIK 0001716043 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the Company's common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds.

F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of the Company's common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds.

F3 · derivative.expiration_date: Each performance stock unit represents a contingent right to receive one share of the Company's common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 20:17 UTC
Hahne VickyChief Financial Officer
GrantCommon Stock 16,000 $0.00 $0.00
Disclosure

SEC source: 0001716043-26-000002 · form4-08182026_080833.xml · nonDerivative · entry 1

Hahne Vicky · CIK 0001716043 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,808

F1 · shares: 25% of the total number of restricted stock units vests on the first day of the month following each of the first, second, third and fourth anniversaries of the grant date.

F2 · balance_after: Includes 2,948 shares acquired pursuant to the Celcuity Inc. (the "Company") employee stock purchase plan.

Read SEC document
July 14, 2026 Filed Jul 16, 2026 21:42 UTC
BAKER BROS. ADVISORS LPFormer 10% owner
BAKER FELIXFormer 10% owner
BAKER JULIANFormer 10% owner
SaleCommon Stock 2,838,632 $102.50 $290,959,780.00
Disclosure

SEC source: 0001193125-26-306299 · ownership.xml · nonDerivative · entry 2

BAKER BROS. ADVISORS LP · CIK 0001263508 · Former 10% owner

Baker Bros. Advisors (GP) LLC · CIK 0001580575 · Former 10% owner

BAKER FELIX · CIK 0001087940 · Former 10% owner

BAKER JULIAN · CIK 0001087939 · Former 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 4,372,852

F2 · ownership.nature: Baker Bros. Advisors LP (the "Adviser") serves as the investment adviser to 667 and Baker Brothers Life Sciences, L.P. ("Life Sciences" and together with 667, the "Funds"). In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held directly by the Funds. Baker Bros. Advisors (GP) LLC (the "Adviser GP") is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are managing members of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held directly by the Funds. The general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held directly by the Funds.

F3 · ownership.nature: Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose.

F4 · ownership.nature: After giving effect to the transactions reported herein and as a result of their ownership interest in (i) Baker Brothers Life Sciences Capital, L.P. and (ii) Life Sciences, Julian C. Baker and Felix J. Baker each may be deemed to have an indirect pecuniary interest in Common Stock reported in column 5 of Table I held directly by Life Sciences, a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital, L.P., a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital (GP), LLC, due to their interest in Life Sciences and Baker Brothers Life Sciences Capital, L.P.'s right to receive an allocation of a portion of the profits from Life Sciences.

Read SEC document
July 14, 2026 Filed Jul 16, 2026 21:42 UTC
BAKER BROS. ADVISORS LPFormer 10% owner
BAKER FELIXFormer 10% owner
BAKER JULIANFormer 10% owner
SaleCommon Stock 261,368 $102.50 $26,790,220.00
Disclosure

SEC source: 0001193125-26-306299 · ownership.xml · nonDerivative · entry 1

BAKER BROS. ADVISORS LP · CIK 0001263508 · Former 10% owner

Baker Bros. Advisors (GP) LLC · CIK 0001580575 · Former 10% owner

BAKER FELIX · CIK 0001087940 · Former 10% owner

BAKER JULIAN · CIK 0001087939 · Former 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 442,940

F1 · ownership.nature: After giving effect to the transactions reported herein and as a result of their ownership interest in (i) Baker Biotech Capital, L.P. and (ii) 667, L.P. ("667"), Julian C. Baker and Felix J. Baker each may be deemed to have an indirect pecuniary interest in common stock ("Common Stock") of Celcuity Inc. (the "Issuer") reported in column 5 of Table I held directly by 667, a limited partnership of which the sole general partner is Baker Biotech Capital, L.P., a limited partnership of which the sole general partner is Baker Biotech Capital (GP), LLC, due to their interest in 667 and Baker Biotech Capital, L.P.'s right to receive an allocation of a portion of the profits from 667.

F2 · ownership.nature: Baker Bros. Advisors LP (the "Adviser") serves as the investment adviser to 667 and Baker Brothers Life Sciences, L.P. ("Life Sciences" and together with 667, the "Funds"). In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held directly by the Funds. Baker Bros. Advisors (GP) LLC (the "Adviser GP") is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are managing members of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held directly by the Funds. The general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held directly by the Funds.

F3 · ownership.nature: Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 16:17 UTC GiftStock Option (right to buy) · Derivative 12,503 $0.00 Strike: $10.69 $0.00
Disclosure

SEC source: 0001688319-26-000010 · form4-06122026_080636.xml · derivative · entry 2

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 12,503

Underlying: Common Stock · 12,503 shares

Expires 2035-05-19

F1 · derivative.exercise_date: 100% vested.

F2 · ownership.nature: The reporting person and his spouse are the trustees and beneficiaries. The reporting person continues to beneficially own these securities held by the trust.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 16:17 UTC GiftStock Option (right to buy) · Derivative 12,503 $0.00 Strike: $10.69 $0.00
Disclosure

SEC source: 0001688319-26-000010 · form4-06122026_080636.xml · derivative · entry 1

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,503 shares

Expires 2035-05-19

F1 · derivative.exercise_date: 100% vested.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 20:18 UTC GiftStock Option (right to buy) · Derivative 14,048 $0.00 Strike: $10.69 $0.00
Disclosure

SEC source: 0001829248-26-000004 · form4-06122026_080606.xml · derivative · entry 2

Murphy Polly A. · CIK 0001829248 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 14,048

Underlying: Common Stock · 14,048 shares

Expires 2035-05-19

F1 · derivative.exercise_date: 100% vested.

F2 · ownership.nature: The reporting person and her spouse are the trustees and beneficiaries. The reporting person continues to beneficially own these securities held by the trust.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 20:18 UTC GiftStock Option (right to buy) · Derivative 14,048 $0.00 Strike: $10.69 $0.00
Disclosure

SEC source: 0001829248-26-000004 · form4-06122026_080606.xml · derivative · entry 1

Murphy Polly A. · CIK 0001829248 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,048 shares

Expires 2035-05-19

F1 · derivative.exercise_date: 100% vested.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 22:23 UTC GrantCommon Stock 1,530 $0.00 $0.00
Disclosure

SEC source: 0001809717-26-000008 · form4-06092026_100642.xml · nonDerivative · entry 1

ROMP CHARLES R · CIK 0001809717 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,745

F1 · shares: Represents restricted stock units that will vest upon the earlier of (i) the 2027 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2027.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 18:22 UTC GrantCommon Stock 1,530 $0.00 $0.00
Disclosure

SEC source: 0001688319-26-000008 · form4-06092026_100610.xml · nonDerivative · entry 1

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,530

F1 · shares: Represents restricted stock units that will vest upon the earlier of (i) the 2027 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2027.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 22:24 UTC
Dalvey DavidDirector
GrantCommon Stock 1,530 $0.00 $0.00
Disclosure

SEC source: 0001296457-26-000008 · form4-06092026_100607.xml · nonDerivative · entry 1

Dalvey David · CIK 0001296457 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,530

F1 · shares: Represents restricted stock units that will vest upon the earlier of (i) the 2027 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2027.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 22:23 UTC GrantCommon Stock 1,530 $0.00 $0.00
Disclosure

SEC source: 0001213869-26-000007 · form4-06092026_100615.xml · nonDerivative · entry 1

NIGON RICHARD · CIK 0001213869 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,565

F1 · shares: Represents restricted stock units that will vest upon the earlier of (i) the 2027 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2027.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 22:25 UTC GrantCommon Stock 1,530 $0.00 $0.00
Disclosure

SEC source: 0001829248-26-000002 · form4-06092026_100617.xml · nonDerivative · entry 1

Murphy Polly A. · CIK 0001829248 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,530

F1 · shares: Represents restricted stock units that will vest upon the earlier of (i) the 2027 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2027.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 22:22 UTC
Furcht LeoDirector
GrantCommon Stock 1,530 $0.00 $0.00
Disclosure

SEC source: 0001775749-26-000002 · form4-06092026_100638.xml · nonDerivative · entry 1

Furcht Leo · CIK 0001775749 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,530

F1 · shares: Represents restricted stock units that will vest upon the earlier of (i) the 2027 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2027.

Read SEC document
June 02, 2026 Filed Jun 4, 2026 20:52 UTC
Laing Lance G.Director · Chief Science Officer
Exercise / conversionStock Option (right to buy) · Derivative 1,000 $0.00 Strike: $9.89 $0.00
Disclosure

SEC source: 0001716041-26-000002 · form4-06042026_080657.xml · derivative · entry 2

Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,250

Underlying: Common Stock · 1,000 shares

Expires 2033-08-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
June 02, 2026 Filed Jun 4, 2026 20:52 UTC
Laing Lance G.Director · Chief Science Officer
Exercise / conversionCommon Stock 1,000 $9.89 $9,890.00
Disclosure

SEC source: 0001716041-26-000002 · form4-06042026_080657.xml · nonDerivative · entry 1

Laing Lance G. · CIK 0001716041 · Director · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,251,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 19, 2026 Filed May 20, 2026 16:58 UTC GiftCommon Stock 1,029 $0.00 $0.00
Disclosure

SEC source: 0001688319-26-000006 · form4-05202026_080520.xml · nonDerivative · entry 2

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 7,789

F1 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
May 19, 2026 Filed May 20, 2026 16:58 UTC GiftCommon Stock 1,029 $0.00 $0.00
Disclosure

SEC source: 0001688319-26-000006 · form4-05202026_080520.xml · nonDerivative · entry 1

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
May 04, 2026 Filed May 6, 2026 16:30 UTC Exercise / conversionStock Option (right to buy) · Derivative 9,000 $0.00 Strike: $5.10 $0.00
Disclosure

SEC source: 0001688319-26-000004 · form4-05062026_080511.xml · derivative · entry 9

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 654

Underlying: Common Stock · 9,000 shares

Expires 2030-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025.

F8 · derivative.exercise_date: 100% vested.

F2 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
May 04, 2026 Filed May 6, 2026 16:30 UTC SaleCommon Stock 365 $143.24 $52,281.80
Disclosure

SEC source: 0001688319-26-000004 · form4-05062026_080511.xml · nonDerivative · entry 7

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 6,760

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025.

F7 · price: The price reported in Column 4 is a weighted average price. These shares of common stock of the issuer were traded in multiple transactions at prices ranging from $143.20 to $143.46, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares traded at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
May 04, 2026 Filed May 6, 2026 16:30 UTC SaleCommon Stock 2,825 $142.04 $401,251.14
Disclosure

SEC source: 0001688319-26-000004 · form4-05062026_080511.xml · nonDerivative · entry 6

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 7,125

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025.

F6 · price: The price reported in Column 4 is a weighted average price. These shares of common stock of the issuer were traded in multiple transactions at prices ranging from $141.59 to $142.50, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares traded at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
May 04, 2026 Filed May 6, 2026 16:30 UTC SaleCommon Stock 2,301 $141.03 $324,503.36
Disclosure

SEC source: 0001688319-26-000004 · form4-05062026_080511.xml · nonDerivative · entry 5

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 9,950

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. These shares of common stock of the issuer were traded in multiple transactions at prices ranging from $140.50 to $141.33, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares traded at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
May 04, 2026 Filed May 6, 2026 16:30 UTC SaleCommon Stock 1,670 $139.58 $233,103.94
Disclosure

SEC source: 0001688319-26-000004 · form4-05062026_080511.xml · nonDerivative · entry 4

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 12,251

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares of common stock of the issuer were traded in multiple transactions at prices ranging from $139.40 to $140.20, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares traded at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
May 04, 2026 Filed May 6, 2026 16:30 UTC SaleCommon Stock 550 $139.00 $76,447.53
Disclosure

SEC source: 0001688319-26-000004 · form4-05062026_080511.xml · nonDerivative · entry 3

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 13,921

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares of common stock of the issuer were traded in multiple transactions at prices ranging from $138.255 to $139.16, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares traded at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
May 04, 2026 Filed May 6, 2026 16:30 UTC SaleCommon Stock 1,289 $137.00 $176,593.00
Disclosure

SEC source: 0001688319-26-000004 · form4-05062026_080511.xml · nonDerivative · entry 2

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 14,471

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025.

F2 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
May 04, 2026 Filed May 6, 2026 16:30 UTC Exercise / conversionCommon Stock 9,000 $5.10 $45,900.00
Disclosure

SEC source: 0001688319-26-000004 · form4-05062026_080511.xml · nonDerivative · entry 1

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 15,760

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025.

F2 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
May 04, 2026 Filed May 6, 2026 20:31 UTC
Dalvey DavidDirector
SaleCommon Stock 25,000 $140.68 $3,517,000.00
Disclosure

SEC source: 0001296457-26-000006 · form4-05062026_080550.xml · nonDerivative · entry 1

Dalvey David · CIK 0001296457 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brightstone Venture Capital Fund, LP

Disclosed balance after: 65,000

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Brightstone Venture Capital Fund, LP ("Brightstone") on August 19, 2025.

F2 · ownership.nature: The reporting person is the General Partner of Brightstone.

Read SEC document
April 09, 2026 Filed Apr 13, 2026 20:02 UTC GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001213869-26-000005 · form4-04132026_080442.xml · nonDerivative · entry 1

NIGON RICHARD · CIK 0001213869 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,035

Read SEC document
March 31, 2026 Filed Apr 2, 2026 16:05 UTC Exercise / conversionStock Option (right to buy) · Derivative 3,000 $0.00 Strike: $5.10 $0.00
Disclosure

SEC source: 0001688319-26-000002 · form4-04022026_080410.xml · derivative · entry 5

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 9,654

Underlying: Common Stock · 3,000 shares

Expires 2030-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025.

F5 · derivative.exercise_date: 100% vested.

F2 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 16:05 UTC SaleCommon Stock 675 $110.83 $74,808.09
Disclosure

SEC source: 0001688319-26-000002 · form4-04022026_080410.xml · nonDerivative · entry 3

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 6,760

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares of common stock of the issuer were traded in multiple transactions at prices ranging from $110.50 to $111.36, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares traded at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 16:05 UTC SaleCommon Stock 2,325 $110.11 $255,995.75
Disclosure

SEC source: 0001688319-26-000002 · form4-04022026_080410.xml · nonDerivative · entry 2

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 7,435

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares of common stock of the issuer were traded in multiple transactions at prices ranging from $109.505 to $110.48, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares traded at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 16:05 UTC Exercise / conversionCommon Stock 3,000 $5.10 $15,300.00
Disclosure

SEC source: 0001688319-26-000002 · form4-04022026_080410.xml · nonDerivative · entry 1

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 9,760

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025.

F2 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 21:29 UTC GrantCommon Stock 215 $0.00 $0.00
Disclosure

SEC source: 0001809717-26-000006 · form4-02132026_090225.xml · nonDerivative · entry 1

ROMP CHARLES R · CIK 0001809717 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215

F1 · shares: Restricted stock that will vest upon the earliest of (i) the 2026 annual meeting of stockholders of Celcuity Inc. or (ii) April 30, 2026.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:31 UTC
Dalvey DavidDirector
SaleCommon Stock 20,000 $120.03 $2,400,538.00
Disclosure

SEC source: 0001296457-26-000003 · form4-01292026_090151.xml · nonDerivative · entry 1

Dalvey David · CIK 0001296457 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brightstone Venture Capital Fund, LP

Disclosed balance after: 90,000

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Brightstone Venture Capital Fund, LP ("Brightstone") on August 19, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.315, inclusive. The reporting person undertakes to provide Celcuity Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The reporting person is the General Partner of Brightstone.

Read SEC document
December 15, 2025 Filed Jan 9, 2026 21:43 UTC GiftCommon Stock 19,975 $0.00 $0.00
Disclosure

SEC source: 0001213869-26-000002 · form4-01092026_090138.xml · nonDerivative · entry 1

NIGON RICHARD · CIK 0001213869 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,035

Read SEC document
December 05, 2025 Filed Dec 9, 2025 16:23 UTC Exercise / conversionStock Option (right to buy) · Derivative 3,000 $0.00 Strike: $5.50 $0.00
Disclosure

SEC source: 0001688319-25-000013 · form4-12092025_091225.xml · derivative · entry 5

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,555

Underlying: Common Stock · 3,000 shares

Expires 2029-12-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 100% vested.

F1 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
December 05, 2025 Filed Dec 9, 2025 16:23 UTC SaleCommon Stock 1,510 $106.04 $160,113.30
Disclosure

SEC source: 0001688319-25-000013 · form4-12092025_091225.xml · nonDerivative · entry 3

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 6,760

F3 · price: The price reported in Column 4 is a weighted average price. These shares of common stock of the issuer were traded in multiple transactions at prices ranging from $106.00 to $106.45, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares traded at each separate price within the range set forth in this footnote.

F1 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
December 05, 2025 Filed Dec 9, 2025 16:23 UTC SaleCommon Stock 1,490 $105.34 $156,956.30
Disclosure

SEC source: 0001688319-25-000013 · form4-12092025_091225.xml · nonDerivative · entry 2

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 8,270

F2 · price: The price reported in Column 4 is a weighted average price. These shares of common stock of the issuer were traded in multiple transactions at prices ranging from $105.00 to $105.70, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares traded at each separate price within the range set forth in this footnote.

F1 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
December 05, 2025 Filed Dec 9, 2025 16:23 UTC Exercise / conversionCommon Stock 3,000 $5.50 $16,500.00
Disclosure

SEC source: 0001688319-25-000013 · form4-12092025_091225.xml · nonDerivative · entry 1

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 9,760

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
December 04, 2025 Filed Dec 8, 2025 21:30 UTC
Furcht LeoDirector
Exercise / conversionStock Option (right to buy) · Derivative 250 $0.00 Strike: $7.60 $0.00
Disclosure

SEC source: 0001775749-25-000006 · form4-12082025_091246.xml · derivative · entry 2

Furcht Leo · CIK 0001775749 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 250 shares

Expires 2025-12-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
December 04, 2025 Filed Dec 8, 2025 21:30 UTC
Furcht LeoDirector
Exercise / conversionCommon Stock 250 $7.60 $1,900.00
Disclosure

SEC source: 0001775749-25-000006 · form4-12082025_091246.xml · nonDerivative · entry 1

Furcht Leo · CIK 0001775749 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2025 Filed Dec 3, 2025 16:09 UTC GiftCommon Stock 500 $0.00 $0.00
Disclosure

SEC source: 0001688319-25-000010 · form4-12032025_091250.xml · nonDerivative · entry 3

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 6,760

F1 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 16:09 UTC Exercise / conversionStock Option (right to buy) · Derivative 1,100 $0.00 Strike: $14.83 $0.00
Disclosure

SEC source: 0001688319-25-000010 · form4-12032025_091250.xml · derivative · entry 5

Buller Richard E · CIK 0001688319 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,522

Underlying: Common Stock · 1,100 shares

Expires 2034-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 100% vested.

F1 · ownership.nature: The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.